Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-03-14 Sale(A) |
2022-03-15 7:12 pm |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
63,340 | $0.31 | $19,635 | 65,292 (Direct) |
View |
2022-03-14 Sale |
2022-03-15 5:01 pm |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
47,132 | $0.38 | $17,910 | 181,500 (Direct) |
View |
2021-01-26 Sale |
2021-01-27 7:32 pm |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
33,868 | $1.73 | $58,592 | 28,632 (Direct) |
View |
2020-09-30 Sale |
2020-10-02 9:00 pm |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
56,130 | $1.64 | $92,053 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-03-31 Option Award |
2023-04-03 8:00 pm |
N/A 2033-03-30 |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2023-03-11 Option Award |
2023-03-14 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
6,666 | $0 | 8,135 (Direct) |
View |
2023-03-11 Tax Withholding |
2023-03-14 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
2,883 | $0.96 | 8,135 (Direct) |
View |
2023-03-11 Exercise |
2023-03-14 6:00 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
6,666 | $0 | 8,135 (Direct) |
View |
2022-03-11 Option Award |
2022-03-15 5:01 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
100,000 | $0 | 181,500 (Direct) |
View |
2022-03-11 Exercise |
2022-03-15 5:01 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
100,000 | $0 | 181,500 (Direct) |
View |
2021-06-23 Option Award |
2021-06-25 4:05 pm |
N/A 2031-06-22 |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
1,936,000 | $0 | 1,936,000 (Direct) |
View |
2021-03-11 Option Award |
2021-03-15 4:30 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2021-01-25 Option Award |
2021-01-27 7:32 pm |
N/A N/A |
Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer |
62,500 | $0 | 28,632 (Direct) |
View |